GE HealthCare (GEHC) announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol

GE HealthCare's announcement of the first patient dosed in its LUMINA clinical trial for a new MRI contrast agent is a significant step forward in demonstrating the potential of their product pipeline.

Newsquawk StaffPublished 23 Apr 2026, 11:49 UTCOn the live feed at 11:29 UTC — 7 more headlines followed before this page went public

Newsquawk headlinesUTC

11:30

An Iranian diplomat told Novosti that a decision on the negotiations could be reached tonight or tomorrow, via Al Hadath

11:30

US War Ministry says forces yesterday boarded the hull of a ship in the Indian Ocean subject to sanctions that was transporting oil from Iran, according to Al Jazeera

11:29

GE HealthCare (GEHC) announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol

11:15

Mobileye Global Inc. (MBLY) Q1 2026 (USD): Adj. EPS 0.12 (exp. 0.09), Revenue 0.558bln (exp. 519mln)

11:13

SuperMicro (SMCI) weakness attributed to traders circulating news that it lost its Oracle (ORCL) contract - UNCONFIRMED

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Context

This advancement not only enhances GEHC's position in the healthcare equipment sector but could also impact investor sentiment positively due to its implications for future revenue growth and innovation in medical imaging. Keep an eye on how this news influences stock momentum and relates to broader trends in health tech investments.

Equities · last 90 days

Recent headlines that moved markets

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

Modest downside seen across equity futures as energy prices tick higher.

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

EQUITIES/26 Aug · 12:56 UTC

States and Meta (META) and agree to settle claims that platforms harmed children, according to a court filing; Meta agrees to pay a maximum of USD 16.68bln to states as part of deal

Market, after we published+2.6%

EQUITIES/8 Sept · 11:48 UTC

AstraZeneca (AZN LN) says Phase III tozorakimab data in COPD showed a 29%-34% reduction in exacerbations.

Market, after we published+1.0%

EQUITIES/7 Sept · 10:54 UTC

Saudi Aramco Jizan oil facilities were reportedly hit in new strikes, the FT reports citing sources; hit on Monday, damage is being assessed.

Equity indices, after we published−0.1%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.